Nuvation Bio reports estimated cash of $765M as of Dec. 31, 2021

Nuvation Bio Inc.

Estimated cash, cash equivalents, and marketable securities of $765M as of December 31, 2021.
Announcement made via Form 8-K on January 10, 2022.
No other financial results or forward guidance provided in the filing.

item 2.02

Nuvation Bio Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-005788

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.